Uncovering hidden progression in MS: Are we making the most of the patient-physician partnership?
Predict, Prevent, Conquer: Beyond Head Pain
An evolving landscape in the treatment of Dravet syndrome (DS) and Lennox-Gastaut syndrome (LGS): the influence of age and patient care
Spinal muscular atrophy: how treatment expectations are evolving across the disease spectrum
Maintaining migraine management during times of a global health crisis
Assessing disease activity for an accurate prognosis of patients with Multiple sclerosis
How can we ensure MS patient care continues to advance through these challenging times?
Outcome measures in adults living with SMA: standardization vs personalization
The early diagnosis of Alzheimer’s disease: delineating the cause of memory impairment
Moving from the periphery to the core of the matter – where does opicapone ▼ fit in Parkinson’s disease?
Ready or Not? What can be done to prepare health care systems for the diagnosis, treatment and care of Alzheimer’s disease in a future with disease modifying therapies?
Pathways to change: Anti-CGRP monoclonal antibodies & the evolving migraine prevention landscape
Complement inhibition in neurological disease: can we prevent damage and regain control? Key findings from phase 3 studies
MS Looking forward: Innovations for individualised patient care
Recognizing & Treating the Many Faces of ATTR Amyloidosis. An update from a neurologist’s perspective
Drug resistant epilepsy: where are we today?
Disputes and Debates: Perspectives on the Early Recognition of Advanced Parkinson’s Disease and Continuous Dopaminergic Stimulation Therapies
Is it time for a new approach in multiple sclerosis management?
Your advice, their decision: Empowering patients to make informed choices
Predict, Prevent, Repair: Gene therapy for motor neurone diseases
Will the Real Multiple Sclerosis please stand up?
A Brain-first perspective in Multiple Sclerosis
Brain penetrance: the new road to take
Gathering core, clinical data sets: Magnetic Resonance Imaging, cognition, McDonald 2017 criteria and diagnosis
Risk stratification: holistic evaluation of prognostic markers to assess risk of progression in patients with Multiple Sclerosis
Risk stratification: what can biomarkers tell us with regard to progression and long-term outcome risks?
Switching between high-efficacy treatments: lessons from Cladribine Tablets
Cannabinoid science: understanding the landscape
Multiple sclerosis treatment decisions and family planning
Gene therapy revolution: an overview for the neurologist
Improving the clinical diagnosis of Alzheimer's disease in the clinic through the use of biomarkers
Cladribine Tablets mechanism of action: efficacy beyond the dosing period.
Chronic sensing in DBS: a new paradigm
Normal Values for Electrodiagnostic Studies
